MRSA vs. Dalvance: Let’s Get Ready To Rumble

MRSA’S MATCH Last week, the FDA approved Dalvance, Chicago-based Durata Therapeutic’s new antibacterial drug for the treatment of methicillin-resistant staphylococcus aureus (MRSA) infections. Why is Dalvance newsworthy? MRSA is an infectionthatis difficult to...